Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: Executive Summary. A Statement for Healthcare Professionals from the Neurocritical Care Society and the Society of Critical Care Medicine

Critical Care Medicine

Volumn 44, Issue 12, 2016, Pages 2251-2257

  Frontera, Jennifer A ^a   Lewin, John J ^b   Rabinstein, Alejandro A ^c   Aisiku, Imo P ^d   Alexandrov, Anne W ^e,f   Cook, Aaron M ^g   Del Zoppo, Gregory J ^h   Kumar, Monisha ⁱ   Peerschke, Ellinor I B ^j   Stiefel, Michael F ^k   Teitelbaum, Jeanne S ^l,m   Wartenberg, Katja E ⁿ   Zerfoss, Cindy L ^o  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^f AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

^g UNIVERSITY OF KENTUCKY   (United States)

^h UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

ⁱ HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^j MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^k NEW YORK MEDICAL COLLEGE   (United States)

^l HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^m MCGILL UNIVERSITY   (Canada)

ⁿ MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^o Lynchburg General Hospital   (United States)

more..

Author keywords

anticoagulant; coagulopathy; guideline; intracranial hemorrhage; reversal

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; BLOOD CLOTTING FACTOR 10A INHIBITOR; FIBRINOLYTIC AGENT; HEMOSTATIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PENTASACCHARIDE; THROMBIN INHIBITOR;

ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; EVALUATION STUDY; HEALTH CARE PERSONNEL; HUMAN; INTENSIVE CARE; INTERNATIONAL NORMALIZED RATIO; PRACTICE GUIDELINE; PRIORITY JOURNAL; CHEMICALLY INDUCED; MEDICAL SOCIETY; NEUROLOGY; PROCEDURES; SECONDARY PREVENTION; STANDARDS; THROMBOEMBOLISM; UNITED STATES;

CRITICAL CARE; FIBRINOLYTIC AGENTS; HUMANS; INTRACRANIAL HEMORRHAGES; NEUROLOGY; SECONDARY PREVENTION; SOCIETIES, MEDICAL; THROMBOEMBOLISM; UNITED STATES;

EID: 84995684276     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000002057     Document Type: Article

References (12)

1. Frontera JA, Lewin JJ 3rd, Rabinstein AA, et al: Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine. Neurocrit Care 2016; 24:6-46
2. Levy JH, Ageno W, Chan NC, et al; Subcommittee on Control of Anticoagulation: When and how to use antidotes for the reversal of direct oral anticoagulants: Guidance from the SSC of the ISTH. J Thromb Haemost 2016; 14:623-627
3. Jaeschke R, Guyatt GH, Dellinger P, et al; GRADE Working Group: Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ 2008; 337:a744
4. Alexander PE, Gionfriddo MR, Li SA, et al: A number of factors explain why WHO guideline developers make strong recommendations inconsistent with GRADE guidance. J Clin Epidemiol 2016; 70:111-122
5. Rosand J, Eckman MH, Knudsen KA, et al: The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 2004; 164:880-884
6. Guyatt GH, Oxman AD, Schünemann HJ, et al: GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol 2011; 64:380-382
7. Guyatt GH, Schünemann HJ, Djulbegovic B, et al: Guideline panels should not GRADE good practice statements. J Clin Epidemiol 2015; 68:597-600
8. Brozek JL, Akl EA, Alonso-Coello P, et al; GRADE Working Group: Grading quality of evidence and strength of recommendations in clinical practice guidelines Part 1 of 3 An overview of the GRADE approach and grading quality of evidence about interventions. Allergy 2009; 64:669-677
9. Flaherty ML, Kissela B, Woo D, et al: The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology 2007; 68:116-121
10. Veltkamp R, Rizos T, Horstmann S: Intracerebral bleeding in patients on antithrombotic agents. Semin Thromb Hemost 2013; 39:963-971
11. Franke CL, de Jonge J, van Swieten JC, et al: Intracerebral hematomas during anticoagulant treatment. Stroke 1990; 21:726-730
12. Flibotte JJ, Hagan N, O'Donnell J, et al: Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 2004; 63:1059-1064